14.6 C
New York
Saturday, November 21, 2026
- Advertisement -spot_img

TAG

ADPKD

Exaluren trial cleared for rare kidney disease study

Exaluren has FDA IND clearance for nonsense-mutation ADPKD, opening US sites for the EXPRESS Phase 2 trial of about 60 patients from Q3 2027.

Latest news

- Advertisement -spot_img